
BioNTech lowers full-year revenue outlook on COVID-19 seasonality, inventory write-downs
(Reuters) – German drugmaker BioNTech on Monday lowered its guidance for full-year revenue, citing C...
4th November, 2024

(Reuters) – German drugmaker BioNTech on Monday lowered its guidance for full-year revenue, citing C...
4th November, 2024

SYDNEY (Reuters) – King Charles visited a skin cancer clinic in Sydney on Tuesday where he met cance...
23rd October, 2024

By Amina Niasse NEW YORK (Reuters) – As CVS Health’s new CEO David Joyner steps into the top job aft...
22nd October, 2024

LONDON (Reuters) – Pfizer on Monday won a bid in a London court to invalidate two of GSK’s patents r...
8th October, 2024

(Reuters) – England’s National Health Services will offer Eli Lilly’s weight-loss drug to nearly a q...
4th October, 2024

The Philippines faces a persistent challenge with financial literacy. In 2022, a study conducted by...
30th September, 2024

(Reuters) – Novo Nordisk’s chief executive is preparing for a showdown next week with U.S. Senator B...
23rd September, 2024

(Reuters) -The European Medicines Agency backed the use of Novo Nordisk’s popular drug Wegovy to hel...
20th September, 2024

By Amina Niasse NEW YORK (Reuters) – U.S. telehealth company Hims & Hers Health on Wednesday said it...
19th September, 2024

(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of it...
13th September, 2024

PARIS (Reuters) -The French farm ministry on Tuesday said it detected five likely cases of food-born...
11th September, 2024

SAO PAULO (Reuters) -A suspected case of mpox in a passenger at Brazil’s main international airport...
27th August, 2024